CBFB/MYH11 Fusion Transcripts in A Case of Acute Myelogenous Leukemia (M1) with Partial Deletion of the Long Arm of Chromosome 16
スポンサーリンク
概要
著者
-
USUKI Kensuke
NTT Kanto Medical Center
-
Usuki Kensuke
Division Of Hematology Ntt Kanto Medical Center
-
Usuki Kensuke
The Division Of Hematology
-
URABE Akio
Division of Hematology, NTT Kanto Medical Center
-
IKI Seiko
Division of Hematology, NTT Kanto Medical Center
-
URABE Akio
The Division of Hematology
-
Urabe A
Ntt Kanto Medical Center
-
Nakatsu Masami
Institute Of Medical Information Kanto Teishin Hospital
-
ENDO Mitsue
Division of Hematology, Kanto Teishin Hospital
-
OSAWA Mayumi
Division of Hematology, Kanto Teishin Hospital
-
KITAZUME Koichi
Division of Hematology, Kanto Teishin Hospital
-
KITAZUME Koichi
the Division of Hematology, Kanto Teishin Hospital
-
ENDO Mitsue
the Division of Hematology, Kanto Teishin Hospital
-
OSAWA Mayumi
the Division of Hematology, Kanto Teishin Hospital
-
IKI Seiko
the Division of Hematology, Kanto Teishin Hospital
-
ARAI Masanobu
Institute of Medical Information, Kanto Teishin Hospital
-
Osawa Mayumi
Division Of Hematology Kanto Teishin Hospital
-
Kitazume Koichi
Division Of Hematology Kanto Teishin Hospital
-
Endo M
Iwate Medical Univ. School Of Medicine Morioka Jpn
-
Arai Masanobu
Institute Of Medical Information Kanto Teishin Hospital
-
Iki Seiko
Division Of Hematology Ntt Kanto Medical Center
関連論文
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes : A Japanese Multicenter Randomized, Controlled Study
- Tyrosine Phosphorylation of Proteins in Primary Human Myeloid Leukemic Cells Stimulated by Macrophage Colony-Stimulating Factor: Analysis by Disease Type and Comparison With Normal Human Hematopoietic Cells
- Cyanamide-Induced Granulocytopenia
- Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules
- Stable Response after Administration of Stem Cell Factor Combined with Granulocyte Colony-Stimulating Factor in Aplastic Anemia
- Chronic neutrophilic leukemia associated with chronic lymphocytic leukemia
- Administration of granulocyte colony-stimulating factor during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia
- CBFB/MYH11 Fusion Transcripts in A Case of Acute Myelogenous Leukemia (M1) with Partial Deletion of the Long Arm of Chromosome 16
- Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia
- Combination Therapy with Granulocyte Colony-Stimulating Factor, All-Trans Retinoic Acid, and Low-Dose Cytotoxic Drugs for Acute Myelogenous Leukemia
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)